Browse Studies — Arctuva

Observational

Prospective Randomized Controlled Comparison of Holmium Laser Enucleation of the Prostate With Robotic Water Jet Ablation

This study compares two FDA-approved surgical treatments for benign prostatic hyperplasia (BPH): Holmium Laser Enucleation of the Prostate (HoLEP) with MOSES 2…

Benign Prostate Hypertrophy(BPH)Lower Urinary Track Symptoms

Estimated

~$10 – $6,250

The Methodist Hospital Research InstituteNCT07772232

Phase 4

Is Silodosin Effective for Treating Lower Urinary Tract Symptoms in Female Patients With Multiple Sclerosis? A Randomized Controlled Trial

The goal of this clinical trial is to learn if silodosin works to treat lower urinary tract symptoms (LUTS) in female patients with multiple sclerosis (MS). It…

Multiple SclerosisLower Urinary Track Symptoms

Estimated

~$10 – $6,250

Atlantic Health SystemNCT07614321

Intradetrusor Onabotulinumtoxin A (Botox) at the Time of Transurethral Resection of the Prostate or Transurethral Waterjet Ablation of the Prostate for Mixed Lower Urinary Tract Symptoms

Patients with longstanding obstructive lower urinary tract symptoms (LUTS) due to benign prostatic hypertrophy (BPH) can also develop symptoms of overactive bl…

Benign Prostatic Hypertrophy (BPH)Lower Urinary Track Symptoms

Estimated

~$10 – $1,125

Benaroya Research InstituteNCT07377929

Phase 2

A Phase 2b Randomized, Single-Center, Double Blind, Placebo Controlled, 2-Arm Study to Investigate Orally Administered Combination Therapies (5-alpha Reductase Inhibitor + Raloxifene) Compared With Monotherapy (5-alpha Reductase Inhibitor + Placebo) in Adult Patients With Benign Prostatic Hyperplasia (BPH)

SRD5A2 is a critical enzyme for prostatic development and growth, and the SRD5A2 inhibitor, finasteride, is used to treat benign prostatic hyperplasia (BPH). S…

BPH (Benign Prostatic Hyperplasia)Lower Urinary Track Symptoms

Estimated

~$10 – $6,250

Beth Israel Deaconess Medical CenterNCT06944145